About Us

Italy

Androgen Excess and PCOS Society

The Androgen Excess and PCOS Society is an international organization dedicated to promoting the generation and dissemination of knowledge related to all aspects of androgen excess disorders including:

  • Polycystic Ovary Syndrome
  • Adrenal Hyperplasia
  • Idiopathic Hirsutism
  • Premature Adrenarche

Members include scientists and clinicians, whose major interests are the etiology, diagnosis, treatment and prevention of androgen excess disorders. The Society disseminates information to both the medical and scientific community and the general public.


Our Mission

To promote knowledge, and original clinical and basic research, in every aspect of androgen excess disorders in order to improve the understanding, diagnosis, treatment, and prevention of these disorders.

The Society will strive to serve as the premier international multidisciplinary organization fostering and encouraging quality and innovation in clinical and basic research related to the etiology, diagnosis, treatment, and prevention of androgen excess disorders.

  • Promote excellence in basic and clinical research in androgen excess that improves the detection and treatment of these disorders.
  • Serve as a forum for the exchange of ideas between professionals from different scientific and clinical backgrounds, striving to stimulate evidence-based studies that guide the management of these disorders.
  • Educate research-sponsoring agencies in the U.S. and elsewhere, either alone or in partnership with patient groups, regarding the importance, priorities, and need for funding of studies of androgen excess disorders.
  • Provide a platform for investigators in search of collaborators, either for additional expertise or to aid in subject recruitment.
  • Produce and disseminate information regarding androgen excess disorders for patients and the general public.
  • Provide a forum for the collection and dissemination of recent findings in androgen excess research, either published or presented at meetings.
  • Participate in evidenced-based guidelines for screening, diagnosis, and treatment of androgen excess disorders.
  • Provide a forum for the direct exchange of ideas through the sponsorship or co-sponsorship of scientific meetings.

The field of androgen excess research, particularly the study of polycystic ovary syndrome (PCOS) and its relationship to metabolic abnormalities, grew exponentially during the 1990s. This was associated with an increased awareness of the disorder among patients and the general public, the increasing degree of collaboration among investigators from different disciplines, and pharmaceutical interests, which as a result drove specific research in this area. As it became evident that the number of patients with androgen excess represented a significant fraction of the population, and as the number of investigators in this area was growing rapidly, the need for an androgen excess investigator-initiated society became increasingly evident. Read More

Elisabet Victorin

Elisabet Victorin, Ph.D.
President

Karolinska Institutet

Stockholm, Sweden

athleen Hoeger

Kathleen Hoeger, M.D., M.P.H.
President-Elect

University of Rochester

Rochester, USA

anuja

Helena Teede, M.B.B.S., Ph.D.
Past President

Monash University

Clayton, Australia

dan

Daniel Dumesic, M.D.
Secretary-Treasurer

University of California, Los Angeles

Los Angeles, USA

enrico

Enrico Carmina, M.D
Executive Director and CEO

University of Palermo

Palermo, Italy

azziz

Ricardo Azziz, M.D., M.P.H., M.B.A.
Senior Executive Director

Georgia Regents University

Augusta, USA

anuja

Anuja Dokras, M.D., Ph.D.
Director-at-Large

University of Pennsylvania

Philadelphia, USA

Piltonen

Terhi Piltonen, M.D., Ph.D.
Director-at-Large

University of Oulu

Oulu, Finland

tania

Tania Burgert, M.D.
Director-at-Large

University of Missouri-Kansas City School of Medicine

Kansas City, USA

laven

Joop Laven, M.D., Ph.D.
Director-at-Large

Erasmus Medical Centre

Rotterdam, The Netherlands

elisabet

Elisabet Victorin, Ph.D.
Nominating Committee

Karolinska Institutet

Stockholm, Sweden

laven

Joop Laven, M.D., Ph.D.
Publication Committee

Erasmus Medical Centre

Rotterdam, The Netherlands

tania

Tania Burgert, M.D.
Patient and Provider Education Committee

University of Missouri-Kansas City School of Medicine

Kansas City, USA

dan

Daniel Dumesic, M.D.
Guidelines Committee

University of California, Los Angeles

Los Angeles, USA

anuja

Anuja Dokras, M.D.
Fundraising Committee

University of Pennsylvania

Philadelphia, USA

lujan

Marla Lujan, Ph.D.
Website Committee

Cornell University

Ithaca, USA

goodarzi

Mark Goodarzi, M.D., Ph.D.
Annual Meeting Scientific Program Committee

Cedars-Sinai Medical Center – UCLA

Los Angeles, United States

Brink

Heidi Vanden Brink, M.Sc., RDMS.
Co-President

Cornell University

Ithaca, United States

Meyer

Michelle Meyer, Ph.D., MPH.
Co-President

University of North Carolina at Chapel Hill

Chapel Hill, United States

Sanchez

Ninive Sanchez, Ph.D, MS, MSW.
Secretary

University of Missouri

Columbia, United States

lujan

Marla Lujan, Ph.D.
Faculty Lead

Cornell University

Ithaca, USA